Form D · Other Technology
Keygen Labs, Inc.
New York, NY · CIK 0001997604
Offering snapshot reported Nov 14, 2023 · SEC filing
- Reported sold
- $3.48M Offering amount: $3.64M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 8, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 14, 2023 | Initial | $3,475,000 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-497126
Source: Form D, filed Nov 14, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Abhinav Bhardwaj | Executive |
| Siddharth Jain | Director |
| Utkarsh Sinha | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
275 W 96 Th Street, Apt 26 F
New York, NY, 10025
New York, NY, 10025